GLP-1 drugs may reach fewer than one in 10 people who need them, experts predict

The World Health Organization (WHO) has announced its official guidance on the use of GLP-1 drugs for treating obesity. GLP-1 drugs are medications that mimic the natural hormone glucagon-like peptide-1 (GLP-1), which are most commonly used for type 2 diabetes and medical weight loss. The first guideline, released on Dec. 1, aims to address the […]

WHO backs GLP-1 meds like Ozempic to treat obesity

The World Health Organization is backing GLP-1 medications for the treatment of obesity, which some advocates hope will open up access to the drugs and improve affordability. Brands such as Ozempic and Wegovy are already wildly popular in North America. »»» Subscribe to CBC News to watch more videos: http://bit.ly/1RreYWS For breaking news, video, audio […]

WHO Issues First-Ever Guidelines for Use of GLP-1 Drugs to Treat Obesity

The WHO recommended GLP-1s as a treatment for obesity alongside a healthy diet and regular exercise. Milles Team/Stocksy New guidelines from the World Health Organization (WHO) recommend using GLP-1 medications to help manage obesity. The agency said the weight-loss drugs should be used in conjunction with a healthy diet and regular exercise. Experts say the […]

Trump GLP-1 Deal ‘Move in Right Direction’

Trump’s deal with drug manufacturers lowering the cost of GLP-1s will expand coverage for many patients. Caroline Messer, MD, explains why she welcomes this deal. Medscape Gastroenterology